LIMNW stock

Liminatus Pharma, Inc. Warrants (LIMNW) financials · $2.4M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Liminatus Pharma, Inc. Warrants (LIMNW) $2.4M cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$2.97M-$3.33M
Net Income-$10.2M-$3.55M
EPS (Diluted)N/AN/A
Cached annual balance sheet
LineFY2025
Total Assets$512.8K
Current Assets$500.6K
Cash & Equivalents$337.7K
PP&E$12.2K
Total Liabilities$10.3M
Current Liabilities$10.3M
Short-term Debt$1.44M
Total Debt$1.44M
Shareholders' Equity-$9.81M
Retained Earnings-$38.9M

† Total Debt: Derived from short-term debt only (no total or long-term debt stored).

Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$9.96M-$1.45M
CapEx$13.1KN/A
Investing Cash Flow-$788.1K-$2.85M
Financing Cash Flow$11.0M$3.92M
Net Change in Cash$281.3K-$378.1K
Free Cash Flow-$9.98MN/A
These statements as JSON? API free 100/day

FAQ

What is LIMNW P/E and revenue?

Liminatus Pharma, Inc. Warrants (LIMNW) $2.4M cap.

What is LIMNW revenue?

LIMNW income-statement cache has no revenue figure yet.

Is LIMNW profitable?

Liminatus Pharma, Inc. Warrants last cached net income is -$10.2M (FY2025).

What are LIMNW total assets?

Liminatus Pharma, Inc. Warrants last cached total assets are $512.8K (FY2025).

What is LIMNW free cash flow?

Liminatus Pharma, Inc. Warrants last cached free cash flow is -$9.98M (FY2025).

Not investment advice. Cached statements, not a live tape.